Elysium Therapeutics, founded in 2013 and headquartered in Danville, California, is a biotechnology company dedicated to healthcare innovations, particularly in the fields of fitness and robotics. The company's core mission is to reduce suffering through advanced medical solutions. Elysium Therapeutics focuses on developing SMART™ drugs, safer opioids, and more effective rescue agents to combat opioid overdoses, particularly those involving synthetic opioids like fentanyl.

Notable affiliated individuals and investors include experts in biotechnology and healthcare innovation. Elysium Therapeutics has achieved significant milestones, including pioneering new safety standards in the opioid industry and developing alternatives to existing rescue agents like Narcan®. Their work has had a profound impact on public health by addressing the leading cause of death for U.S. adults aged 18-45, thereby saving countless lives.